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Abstract 
Objective Patient adherence with treatment recommendations is an essential factor 
for the effectiveness of cervical cancer screening programmes. Psychological factors 
may play a role in patient adherence to cervical cancer screening. The present study 
aimed to extend knowledge of women’s adherence to follow-up colposcopy, by 
examining possible predictive biopsychosocial variables measured at colposcopy 
and objective attendance rates from patients’ medical files.   
Methods Baseline data on psychosocial factors (e.g. demographic variables, state 
anxiety, and pain) was collected from 141 women prior to undergoing colposcopy 
for the first time (M age = 29.63, SD = 8.39). Experiences of colcopscopy and 
adherence to follow-up (within two years) were assessed subsequently. 
Results There were no associations between adherence and demographic variables. 
Women with severe dysplasia were more likely to adhere to follow-up colposcopy 
than women with other histology grades. Women who did not attend for follow-up 
reported significantly greater state anxiety and pain unpleasantness following 
colposcopy than women who did attend. A multivariate logistic regression analysis 
revealed that the psychological experiences of colposcopy did not predict adherence 
status.  However, dysplasia severity made a significant contribution to the model. 
The odds of adhering to colposcopy for patients with severe dysplasia were 3.57 
times higher than for patients with normal histology, and 4.35 times higher than for 
patients with moderate dysplasia (p = .005).   
Conclusions Colposcopy-related experiences do not appear to be strong predictors 
of adherence, but women with dysplasia grades other than ‘severe’ should be 
targeted for follow-up recommendations and advice.  
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Introduction 
Cervical cancer represents a major public health problem. The most recent 
global figures estimate that there were 493 000 new cases and 274 000 deaths from 
the disease in 2002 [1]. In the USA, the incidence rate is 8.1 per 100 000 women 
and the mortality rate is 2.4 per 100 000 women [2]. Cervical cancer can be 
prevented by early detection of cervical intraepithelial neoplasia (CIN) by 
cytological smear testing and follow-up treatment before progression into invasive 
disease. Colposcopy and directed biopsy provide a colposcopic impression and 
histologic diagnosis which forms the basis of treatment recommendations following 
an abnormal smear test.  
At all stages throughout the cervical cancer screening cycle, from cytological 
screening to treatment, adherence remains a major issue; both in follow-up of 
abnormal smear test results and adherence to treatment recommendations after 
colposcopy [3, 4]. Adherence at colposcopy clinics is an essential factor for 
effectiveness of a cervical cancer screening program, as progression of CIN is most 
likely to occur in those women who do not attend each stage of the screening cycle 
[5-7]. A recent study suggested that 13% of invasive cervical cancers were 
attributable to non-adherence to follow-up of abnormal cervical smear test results 
[8]. Women may default at any stage of the screening cycle, and for colposcopy it 
has been reported that most women default during follow-up or at the review stage 
[9].  
Psychological factors, particularly psychological distress, may play a role in 
patient adherence to cervical cancer screening. Women experience significant 
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emotional reactions in response to colposcopy [10, 11], and psychological factors 
may further influence the disease process [12, 13]. Fear has been most often cited 
for non-adherence to colposcopy. The results from a prospective study of 40 
defaulters found that women reported fear of cancer, fear of an internal examination, 
and fear of further pain associated with biopsy and treatment as reasons for non-
attendance at colposcopy [9]. Furthermore, anxiety has been suggested as an 
important factor in determining adherence to colposcopy, although there is no 
research evidence  to suggest that decreasing anxiety improves adherence rates [14]. 
Although it has also been suggested that pain experienced during colposcopy may 
contribute to non-adherence to follow-up appointments [15], there are no published 
accounts of studies that have explored the relationship between pain and adherence.  
While some patient characteristics have been found to influence adherence to  
recommended care following an abnormal smear test results, such as age, smoking 
status, knowledge of smear test, and lesion severity [16-19], little is known about 
how the experience of colposcopy influences adherence to follow-up 
recommendations. In order to intervene appropriately and effectively to reduce 
negative psychological consequences of cervical cancer screening and to promote 
adherence to care in this patient group, it is important to understand the 
characteristics of the population where such intervention is planned [6]. The present 
study was conducted in order to further extend understanding of women’s adherence 
to follow-up colposcopy, by examining possible predictive variables measured at 
first colposcopy and objective attendance rates of follow-up from patients’ medical 
files.  
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Methodology 
Design 
This study employed a prospective design. Baseline data from 164 first-time 
colposcopy patients were correlated with data on adherence to follow-up treatment 
taken from medical files approximately two years following first colposcopy. Of 
these 23 (14%) were discharged following colposcopy and returned to the 
cytological screening cycle as their examinations revealed no abnormalities, leaving 
a sample of 141 women for analysis. 
All procedures were reviewed and approved by the local hospital research 
ethics committee.   
 
Study Setting and Participants  
Participants were 141 women consecutively recruited from a colposcopy 
clinic in a university hospital in Ireland. All women were first-time colposcopy 
patients at the time of the study enrollment, having been referred with an abnormal 
cervical smear result. Exclusion criteria included severe cardiac, pulmonary, or liver 
disease, epilepsy or chronic pain, to reduce differences in health status.  
 
 
Measures  
Adherence rates  
Data on adherence was obtained from the computer records at the clinic 
approximately two years from the time of the first clinic appointment. In accordance 
with previous research, women who had not adhered to follow-up colposcopy within 
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a period of 4 months of original appointment date were classified as ‘non-adherent’ 
[3, 20].    
 
Demographic and medical information  
The background self-report information included age, marital status, 
education, parity, and smoking status. From the medical charts, cytology and 
histology results were extracted. Cytology and histology grades are reported 
according to the Bethesda classification, with the British Society of Clinical 
Cytology (BSCC) classification in brackets. The following cytology grades were 
found: unsatisfactory/inadequate, atypical squamous cells of undetermined 
significance (borderline nuclear abnormalities [BNA sqamous]), low grade 
squamous intraepithelial lesion (mild dyskaryosis), high grade squamous 
intraepithelial lesion (moderate and severe dyskaryosis). The following histology 
grades were found: normal, viral changes, CIN1 (mild dyskaryosis), CIN2 
(moderate dykaryosis), CIN3 (severe dyskaryosis), and carcinoma in situ. The 
histology grades were collapsed as follows: normal, mild (viral changes and CIN1), 
moderate, severe (CIN 3 and carcinoma in situ).    
 
State-Trait Anxiety Inventory (STAI) 
Trait anxiety and post-colposcopy state anxiety, as measured by the STAI 
[21], were used for the present analyses. The Trait form measures the frequency of 
respondents’ feelings in general using 20 items, while the State form assesses the 
frequency of respondents’ feelings at the present moment, using 20 items. Each item 
is measured on a four-point Likert scale ranging from ‘not at all’ to ‘very much so’. 
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The possible range of scores for the scales is 20-80, with a higher score indicating 
greater anxiety. Reliability and validity of this scale has been established, and 
Cronbach’s alpha of .91 for the trait form, and .93 for the state form have been 
reported [21]. For the present sample, Cronbach’s alpha was .89 for the trait form, 
and .92 for the state form.  
 
Experienced pain  
 Immediately following the colposcopy examination, patients responded to 
two 100-mm visual analogue scales (VAS) assessing experienced pain intensity and 
pain unpleasantness during colposcopy. The VASs were anchored by ‘no pain/no 
discomfort’ and ‘pain as bad as it could be/worst discomfort’ at either end. To score 
the VASs, the distance from the ‘no pain’ or ‘no discomfort’ anchors to the 
respondent’s mark is measured, and a higher score signifies greater pain and 
discomfort. Test-retest reliability have been established [22], and high correlations 
with other pain rating scales have been demonstrated [23, 24]. 
In addition, the peak pain scale of the McGill Pain Questionnaire [25] was 
used in the present analyses. This requires respondents to indicate their peak pain 
using one of the following numbers: (0) no pain, (1) mild, (2) discomforting, (3) 
distressing, (4) horrible, and (5) excruciating. Reliability and validity have been 
established [see 26]. 
 
Procedure  
Women eligible for participation were individually invited into a quiet office 
adjacent to the colposcopy room, and invited to participate in a study on women’s 
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experiences of their first visit to the colposcopy clinic. Each woman was 
administered the study questionnaire examining demographic variables and trait 
anxiety before the colposcopy examination. Immediately following colposcopy, 
experiences of colposcopy including pain and anxiety were assessed.  
   
Statistical analysis  
A series of preliminary t-test and chi-square analyses were conducted. For 
the purposes of the chi-square analyses, the following variables were collapsed: age 
(under 25 vs. 25 and over), marital status (single vs. married), parity (no children vs. 
have children), education (less than college education vs. college education), 
smoking status (non-smoker vs. smoker), cytology grade of referral smear (all other 
smear grades vs. high grade smear), and histology grade at first colposcopy 
(normal/mild/moderate/severe).   
A multivariate logistic regression analysis was conducted, with adherence to 
follow-up colposcopy (coded 0 = non-adherent, and 1 = adherent) as the dependent 
variable in the model. Based on the results from the preliminary analyses the 
variables that showed significant univariate association with adherence were 
included in the logistic regression analysis. 
 
Results 
The final sample consisted of 141 women (M age = 29.63 years, SD = 8.39) 
who received follow-up colposcopy appointments, 92 women (65%) adhered, and 
49 (35%) were non-adherent. There was no statistically significant difference in 
mean age of women who adhered or did not adhere to follow-up colposcopy 
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appointments at the time of initial colposcopy. However, women who were non-
adherent reported significantly greater state anxiety and pain unpleasantness 
following colposcopy than women who adhered to follow-up colposcopy. The 
descriptive statistics are presented in Table 1.  
---------------------------- 
Insert Table 1 about here 
------------------------------ 
Chi-square results  
A series of preliminary chi-square
 
analyses revealed no significant 
association between adherence status and the following variables: age, marital 
status, parity, education, smoking status, smear grade on referral, whether patient 
had biopsy at first colposcopy, or whether patient had treatment at first colposcopy. 
However, differences in adherence were found in histology diagnosis of dysplasia 
severity, such that women with severe dysplasia were more likely to adhere to 
follow-up colposcopy than women with other histology grades. See Table 2 for 
summary statistics 
---------------------------- 
Insert Table 2 about here 
------------------------------ 
 
Multivariate logistic regression 
The variables with significant independent associations with adherence 
status (post-colposcopy state anxiety, pain unpleasantness and histology grade) were 
entered into the logistic regression analysis. The results of the multivariate logistic 
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regression are summarised in Table 3. A test of the full model against a constant 
only model was statistically significant, indicating that the predictors as a set 
reliably distinguished between adherence status, χ2 (5) = 16.69, p = .005.  Prediction 
success overall was 67%. The Wald statistic demonstrated that only dysplasia 
severity made a significant contribution to the model. Post-colposcopy state anxiety 
and pain unpleasantness were not significant predictors of adherence to follow-up 
colposcopy. Inverted odds ratios indicated that the odds of adhering to follow-up 
colposcopy for women with severe dysplasia were 3.57 times higher than for 
patients with normal histology, and 4.35 times higher than for women with moderate 
dysplasia.  
---------------------------- 
Insert Table 3 about here 
------------------------------ 
 
Discussion 
In this group of women who were initially assessed at their first-ever 
colposcopy appointment, 35% failed to adhere to recommendations to attend follow-
up colposcopy within a period of four months following the original (repeat) 
appointment. The aim of this study was to identify factors which predict adherence 
to follow-up colposcopy. The results from bivariate analyses demonstrated that 
women with histology confirmed severe dysplasia were more likely to adhere to 
follow-up colposcopy than women with other dysplasia grades. In the logistic 
regression analysis, dysplasia severity emerged as a significant predictor of 
adherence. Particularly, it was found that for women with severe dysplasia the odds 
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of adhering to follow-up were 3.57 times higher than for women with normal 
histology, and 4.35 times higher than for women with moderate dysplasia. These 
results are in line with other studies which have found that non-adherent women are 
less likely to have high grade lesions than women who adhere to follow-up 
recommendations [27-29].     
It is possible that the follow-up time intervals are shorter for women with 
more severe dysplasia grades, or that women with low-grade dysplasia perceive 
lower risk of developing cervical cancer, and therefore are less likely to adhere to 
follow-up recommendations. Women may perceive that the seriousness of the 
abnormality is conveyed by the urgency in requiring follow-up [see 29].  
It has been found that the nature of the follow-up influence adherence rates, 
such that higher adherence rates are observed for more intensive follow-up 
compared to less intensive follow-up. Specifically, it was found that the adherence 
rate for conization was 85%, 81% for LLETZ treatment, 62% for repeat colposcopy, 
and 36% for repeat cytology [30]. A related factor may be the length of time 
between original colposcopy and follow-up appointment, with greater non-
adherence with increased time intervals [31].  
Furthermore, it was revealed that women who did not attend for repeat 
colposcopy reported significantly greater state anxiety and pain unpleasantness 
immediately following first colposcopy than women who attended for follow-up 
colposcopy.  However, in the logistic regression neither pain unpleasantness 
experienced during colposcopy nor anxiety reported immediately following 
colposcopy influenced adherence rates in the present sample. The results from the 
present study thus suggest that anxiety and pain experiences during initial 
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colposcopy are not strong predictors of follow-up recommendations, when 
considered in combination with other variables. This is in contrast to suggestions 
that have been made in the literature, linking anxiety and pain experiences during 
colposcopy to follow-up colposcopy adherence [14, 15]. It is interesting to note that 
few prospective studies appear to have investigated these suggestions. Radecki 
Breitkopf and Pearson found that affect (fear, sadness, or rejection) was not 
associated with intentions to attend follow-up recommendations [32].   
There were no associations between adherence to follow-up colposcopy and 
most of the demographic variables (i.e., age, marital status, parity, education, 
smoking status, or smear grade on referral). Our finding of no association between 
demographic variables and adherence is consistent with the majority of previous 
studies [27, 33]. For example, a recent Australian study found no differences in 
demographic variables, including age, parity, pregnancy, smoking status, 
immunosuppression status, presenting smear test and HPV status, of women who 
did or did not adhere to follow-up colposcopy [34]. This contrasts with other studies 
that have found that non-adherent women are more likely to be younger, 
unemployed or pregnant than adherent women [9]. Another study found that non-
adherent women were younger than adherent women, but found no differences in 
parity or histology result [35].  
There were no associations between adherence to follow-up colposcopy and 
whether or not women underwent biopsy or LLETZ treatment during colposcopy in 
the present study. This is in contrast to one previous study, which found that women 
who underwent treatment for CIN were less likely to adhere to follow-up 
recommendations than women who did not have treatment for CIN [36]. The 
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authors suggest that the reason for this may be due to women experiencing their risk 
of developing cervical cancer as reduced or negligible after treatment of CIN.  
In studies examining adherence after colposcopy, there do not appear to be 
easily identifiable predictive factors that would inform us which patients will adhere 
to follow-up and which patients will not. Therefore, we are still unclear about the 
groups of women that are non-adherent to follow-up colposcopy recommendations.  
In the absence of identifiable predictive factors for non-adherence, and rates of non-
adherence following colposcopy range from 10% to 40% [6] it would seem sensible 
to extend research efforts in this area to find suitable interventions to promote 
adherence.   
The importance of finding effective interventions to promote adherence to 
follow-up care is evident from research that has demonstrated that non-adherence to 
follow-up treatment recommendations has been implicated as a contributing factor 
in adverse outcomes in retrospective analyses of invasive cervical cancer. For 
example, in a retrospective study of 60 women with abnormal smear test results, 
who had received no follow-up treatment, 13 women developed invasive cervical 
cancer, of which 5 died [37]. Women with abnormal smear test findings who do not 
have follow-up treatment are thus at a higher risk of developing invasive cervical 
cancer than women with abnormal smear test findings who receive appropriate 
follow-up treatment [38].  
The strengths of the study include recruitment of women without previous 
experience of colposcopy or treatment for CIN, with one colposcopist carrying out 
all examinations, minimizing differences in experience. A limitation of the data is 
that we were unable to extract complete data of the interval of follow-up colposcopy 
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for women with different histology grades. In addition, it is possible that different 
results may have been obtained if women had been asked to reflect on their 
colposcopy experiences some time after the initial colposcopy, but before the 
follow-up colposcopy. Finally, although the sociodemographic profile of patients 
was similar to those reported in other studies [e.g. 39], all participants were recruited 
from a single institution, potentially limiting generalizability.  
In summary, this study highlights the difficulty in identifying predictors of 
non-adherence to follow-up colposcopy. Dysplasia severity emerged as the only 
significant predictor of adherence, and women with severe dysplasia were more 
likely to adhere to follow-up colposcopy than women with normal histology results 
or moderate dysplasia. Furthermore, the results suggest that colposcopy-related 
experiences, at least when measured immediately following first colposcopy, are not 
strong predictors of adherence to follow-up recommendations.  
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TABLE 1. Descriptive statistics of participants (n = 141).  
 Adherence Status  
 Adherent Non-adherent t  
Variable Mean (SD) Mean (SD)  
Age  30.13 (8.28) 28.69 (8.61) .97 
Trait anxiety 35.47 (7.48) 37.45 (8.69) .16 
State anxiety 34.16 (9.44) 38.02 (11.12) 2.17
*
 
Pain unpleasantness 29.77 (24.10) 39.43 (24.09) 2.27
*
 
Pain intensity 18.03 (21.70) 24.41 (21.07) 1.68 
Peak pain  2.34 (1.50) 2.82 (1.27) 1.90 
* < .05 
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TABLE 2. Summary of chi-squared analyses (n = 141)  
 Adherence Status  
Variable Adherent n (%) Non-adherent n (%) χ2 (df) 
Age    .43 (1) 
25 and under  27 (19.1) 17 (12.1)  
Over 25  65 (46.1) 32 (22.7)  
Marital status   .54 (1) 
Single 62 (44.0) 30 (21.3)  
Married  30 (21.3) 19 (13.5)  
Parity    .49 (1) 
No children 45 (31.9) 27 (19.1)  
Have children  47 (33.3) 22 (15.6)  
Education    1.29 (1) 
Less than college 41 (29.1) 17 (12.1)  
College education 51 (36.2) 32 (22.7)  
Smoking status   .75 (1) 
Non-smoker 63 (44.7) 30 (21.3)  
Smoker 29 (20.6) 19 (13.5)  
Referral smear   .43 (1) 
All other grades 53 (37.6) 31 (22.0)  
High grade 39 (27.7) 18 (12.8)  
Biopsy    .32 (1) 
No  44 (31.2) 21 (14.9)  
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Yes 48 (34.0) 28 (19.9)  
LLETZ treatment   .78 (1) 
No 67 (47.5) 39 (27.7)  
Yes  25 (17.7) 10 (7.1)  
Histology Results   8.50 (3)
*
 
Normal  17 (12.1) 12 (8.5)  
Mild  27 (19.1) 11 (7.8)  
Moderate 14 (9.9) 16 (11.3)  
Severe 34 (24.1) 10 (7.1)  
* < .05 
24 
 
TABLE 3. Logistic regression of experience of colposcopy on adherence to 
follow-up colposcopy   
  95% CI for exp b  
  (SE) Lower Exp b Upper 
Included variables      
Constant 3.13 (.91)
**
  22.96  
State anxiety -.04 (.02) .93 .97 1.01 
Pain unpleasantness -.01 (.01) .97 .99 1.01 
Histology grade     
    Normal -1.27 (.57)* .09 .28 .86 
    Mild  -.64 (.54) .18 .53 1.52 
    Moderate -1.47 (.54)* .08 .23 .66 
Note: R2 = .09 (Hosmer & Lemeshow), .11 (Cox & Snell), .15 (Nagelkerke). Model 
χ2 (5) = 16.69, p = .005.  
* p<.05 
** p<.001 
 
